Pulmonary Arterial Hypertension (PAH) Clinical Trial
Official title:
Untersuchung Des Einflusses PAH-spezifischer Medikation Auf Die rechtsventrikuläre Funktion Bei Patienten Mit Pulmonaler Arterieller Hypertonie (PAH) Unter Basalen Bedingungen
Pilot study to determine the therapeutic effect of two prarallel groups treated with either Riciguat or Macitentan, evaluated by the change in systolic and diastolic RV function within 12 weeks after first drug intake in order to plan a larger Phase II study.
In this multi-center, randomized, open pilot study the therapeutic effect of two prarallel groups treated with either Riciguat or Macitentan shall be determined by evaluating the change in systolic and diastolic RV function within 12 weeks after first drug intake in order to plan a larger Phase II study.The method used to determine the RV function will be the "Conductance Method". ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03145298 -
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy
|
Phase 1 | |
| Recruiting |
NCT03235401 -
The PAH Disability and Bothersomeness Questionnaire
|
N/A | |
| Not yet recruiting |
NCT05947240 -
Effects of UE Aerobic Exercise on Exercise Capacity and PA in Patients With Pulmonary Arterial Hypertension.
|
N/A | |
| Recruiting |
NCT01347216 -
COMPERA / COMPERA-KIDS
|
||
| Completed |
NCT05546125 -
a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China
|
||
| Terminated |
NCT00586794 -
Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients
|
Phase 3 | |
| Completed |
NCT03523910 -
Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension
|
N/A |